Breaking News!

Home
About Us
Resources
Our Stories
News
Events
Donate
Contact us

No results See all results

Our Summer 2013 newsletter is now out!

July 18, 2013

Neonatal Alloimmune Thrombocytopenia – NAIT Survey Study request.

January 26, 2014

Tromplate® the medicine being developed by the PROFNAIT Project, which has already been granted Orphan Drug Status in the EU has just been granted Orphan Drug Status by the FDA in the US!!!!
http://www.profnait.eu/en-parents/donate-plasma/

June 4, 2024

May 2024 – Doctor Thijs W de Vos receives prize for the best dissertation 2023-24 within the field, at the NVB-TRIP Symposium!

May 14, 2024

Care Design New York – Member Spotlight – Meet Chris!!!

April 25, 2024

10 April 2024-FNAIT Collaboration Agreement between Momenta Pharmaceuticals, Inc., a Johnson & Johnson Company, and Rallybio IPA, LLC

If you have been diagnosed with, or suspect that you may have Fetal and neonatal alloimmune thrombocytopenia and would like to join our private parents support forum please email us

Research and treatment protocols are ongoing.

Always consult a qualified medical specialist in this field. Cases of neonatal alloimmune thrombocytopenia should be managed in specialised Fetal Medicine Units.

Follow Our Social Media

Facebook
X
Instagram
Mail

Donate

Home
Privacy Policy
Cookies
Disclaimer

This website uses cookies to improve your experience. By using this website you agree to our Data Protection Policy.

Tromplate® the medicine being developed by the PROFNAIT Project, which has already been granted Orphan Drug Status in the EU has just been granted Orphan Drug Status by the FDA in the US!!!! http://www.profnait.eu/en-parents/donate-plasma/

Related posts

May 2024 – Doctor Thijs W de Vos receives prize for the best dissertation 2023-24 within the field, at the NVB-TRIP Symposium!

Care Design New York – Member Spotlight – Meet Chris!!!

10 April 2024-FNAIT Collaboration Agreement between Momenta Pharmaceuticals, Inc., a Johnson & Johnson Company, and Rallybio IPA, LLC

Tromplate® the medicine being developed by the PROFNAIT Project, which has already been granted Orphan Drug Status in the EU has just been granted Orphan Drug Status by the FDA in the US!!!!
http://www.profnait.eu/en-parents/donate-plasma/